|
See figure below for
most read essays (Jan. - Dec. 07)
*
in list means most read
(top 10)
*Blog
Lab Quality
It's
time to stop advocating the use of the wrong model in clinical
chemistry
*Six Sigma I Some technical comments about Six Sigma
in the lab
Six Sigma II A glucose example and
its problems
Six Sigma III A dubious Six
Sigma claim
Troponin I – Its Performance Doesn’t
Justify Actions
*How to specify and estimate outlier
rates
A Comment about GUM
Why Progress in
Quality is Slow
Equivalent QC
Equivalent QC II
Should labs run more
QC?
Issues with
Standard Groups
ISO Terminology
- Globally harmonized or gobbledygook
FMEA vs. lab performance goals - there's a big difference
Comments on the FDA Guidance for Waiver
Applications
*Fault tree
example as an aid to completing a FMEA
*Risk
Management
Publishing in
Journals or on the web
It's Up To
the Lab Director
The quality
of quality initiatives
Discrepant
Analysis
QC Outlier............s
Uniformity of
Claims
Proficiency testing and six
sigma
More on GUM
Fault Isolation
*Bland Altman Plots
Customer Misuse
Risk Management II
Unit use devices, POC and QC
Risk Management III
new
What it takes to get
your idea accepted
new
Pedigree of Error Reduction Approaches
new
Patient Safety
Frequency of
Preventable Medical Errors – Myth or Reality
Focus on systems, not people
*The anatomy of a near miss
Detection in FMEA - why it should not be
included in a Pareto ranking
Recovery in FMEA
Latent
errors
Preventable
medical errors: Preventability and regulation
*FMEA vs. FRACAS vs. RCA
Pay for performance - the missing measure
*FMEA Validation
Frequency of
Preventable Medical Errors II - Where's the data
Pay for Performance II
Error Reporting
Systems
The Reverse Pareto - not a good idea
When to conduct a FMEA
new
FMEA FRACAS Fault Trees and Pareto new
Management
*How to write a
report that will be read
Beware the
technical Administrator
Programming
Let’s just dump the lab data on the
Internet – not that easy
Software Validation
Based on 38,041 unique views
| 
